| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/03/2001 | EP1064377A1 Casb414: antigen overexpressed in several tumours |
| 01/03/2001 | EP1064375A2 Human calcium-binding proteins |
| 01/03/2001 | EP1064371A2 Isolated mammalian membrane protein genes and related reagents |
| 01/03/2001 | EP1064370A2 Protein phosphatase-related molecules |
| 01/03/2001 | EP1064362A1 Nek1-related protein kinase |
| 01/03/2001 | EP1064354A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 01/03/2001 | EP1064308A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 01/03/2001 | EP1064307A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof |
| 01/03/2001 | EP1064298A2 Inhibitors of caspases |
| 01/03/2001 | EP1064294A1 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them |
| 01/03/2001 | EP1064291A1 Methods of synthesizing gm3 |
| 01/03/2001 | EP1064289A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 01/03/2001 | EP1064277A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 01/03/2001 | EP1064026A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 01/03/2001 | EP1064025A2 Combined vaccine compositions |
| 01/03/2001 | EP1064023A1 Products in the treatment of cancer |
| 01/03/2001 | EP1064022A1 Hla-binding peptides and their uses |
| 01/03/2001 | EP1064020A1 Methods for diagnosing and treating autoimmune disease |
| 01/03/2001 | EP1064018A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/03/2001 | EP1063987A1 Dietary control of arachidonic acid metabolism |
| 01/03/2001 | EP1063984A1 Inflammatory cell inhibitors |
| 01/03/2001 | EP1063982A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 01/03/2001 | EP1063891A2 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby |
| 01/03/2001 | EP0807183B1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 01/03/2001 | EP0787127B1 5-lipoxygenase inhibitors |
| 01/03/2001 | EP0708776B1 Antiallergic imidazoazepines |
| 01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |
| 01/03/2001 | CN1278795A Process for making diaryl pyridines useful as cox-2 inhibitors |
| 01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 01/03/2001 | CN1278739A Method of delivering genes to antigen presenting cells of the skin |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/02/2001 | US6169095 For prevention and/or treatment of bradykinin or its analogues mediated diseases in the eye, such as allergy, inflammation and pain of the eye |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169087 An enzyme inhibitor for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, obesity, autoimmune diseases, diseases with dysfunctions of the coagulation system, allergic diseases, cancer, psoriasis |
| 01/02/2001 | US6169073 An oligopeptide or polypeptide for activating dna binding of wild-type p53 and select tumor-derived p53 mutants; use in therapy of cancer and other disorders characterized by excessive proliferation of certain cells and tissues |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168923 Compositions and methods for use of IL-12 as an adjuvant |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168796 Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides |
| 01/02/2001 | US6168793 Heat shock protein 70 preparations in vaccination against cancer and infectious disease |
| 01/02/2001 | US6168792 Materials and methods for detection and treatment of immune system dysfunctions |
| 01/02/2001 | US6168791 Antibodies that bind immunomodulators |
| 01/02/2001 | US6168787 Pluripotent vaccine against enveloped viruses |
| 01/02/2001 | US6168786 Chimeric protein containing a protein of parainfluenza virus (piv-3) and a protein of respiratory syncytial virus (rsv); capable of protecting infants and similar susceptible individuals against diseases caused by both piv and rsv |
| 01/02/2001 | US6168784 Block the inflammatory effects of rantes, and are useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, rheumatoid arthritis and hiv infections |
| 01/02/2001 | US6168783 Antagonists of interleukin-15 |
| 01/02/2001 | CA2034979C Antibiotic, deoxymulundocandin, a process for its production and its useas medicament |
| 01/02/2001 | CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof |
| 01/02/2001 | CA1341160C Bovine granulocyte-macrophage colony stimulating factor |
| 01/01/2001 | WO2001003645A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 12/29/2000 | CA2300467A1 Cancer vaccines |
| 12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078804A1 Immune response regulatory proteins |
| 12/28/2000 | WO2000078802A2 Secreted polypeptides and corresponding polynucleotides |
| 12/28/2000 | WO2000078794A1 Cysteinyl protease inhibitors |
| 12/28/2000 | WO2000078758A1 Novel imidazole derivatives |
| 12/28/2000 | WO2000078750A1 New pharmaceutically active compounds |
| 12/28/2000 | WO2000078360A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 12/28/2000 | WO2000078353A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 12/28/2000 | WO2000078348A1 Autologous adoptive immunotherapy with primed antigen-specific t cells or b cells |
| 12/28/2000 | WO2000078346A1 Novel anti-allergic agents |
| 12/28/2000 | WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/28/2000 | WO2000078329A2 The use of the protein uk 114 for inhibiting organ transplant rejection |
| 12/28/2000 | WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 12/28/2000 | WO2000078317A1 Integrin receptor antagonists |
| 12/28/2000 | WO2000078303A1 Non-malignant disease treatment with ras antagonists |
| 12/28/2000 | WO2000078266A2 Interferon tau mutants and methods for making them |
| 12/28/2000 | WO2000055162A3 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 12/28/2000 | WO2000053767A3 Nucleic acid respiratory syncytial virus vaccines |
| 12/28/2000 | WO2000048625A3 Inhibitors for use in hemostasis and immune function |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | WO2000043373A3 Kinase inhibitors |
| 12/28/2000 | WO2000032209A3 Submucosa modulation of mammalian immune response |
| 12/28/2000 | WO2000030667A3 Compositions and methods using lactadherin or variants thereof |
| 12/28/2000 | WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors |
| 12/28/2000 | CA2382425A1 Interferon tau mutants and methods for making them |
| 12/28/2000 | CA2377639A1 The use of the protein uk 114 for inhibiting organ transplant rejection |
| 12/28/2000 | CA2377530A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 12/28/2000 | CA2377524A1 Novel anti-allergic agents |
| 12/28/2000 | CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | CA2377263A1 Polynucleotides and polypeptides encoded thereby |
| 12/28/2000 | CA2376829A1 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 12/28/2000 | CA2376081A1 Cysteinyl protease inhibitors |
| 12/28/2000 | CA2376077A1 Integrin receptor antagonists |
| 12/28/2000 | CA2375508A1 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | CA2375493A1 Human transport proteins |
| 12/28/2000 | CA2375414A1 Human transcriptional regulator proteins |
| 12/28/2000 | CA2375407A1 Rna metabolism proteins |
| 12/28/2000 | CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/27/2000 | EP1063228A1 Cycloalkene derivatives, process for producing the same, and use |
| 12/27/2000 | EP1062950A2 1,3 Oxathiolane nucleoside analogues |
| 12/27/2000 | EP1062949A1 IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS |